The NEJM publishes phase 3 PEGASUS study results comparing pegcetacoplan to eculizumab for PNH ...Middle East

STOCKHOLM, Sweden and WALTHAM, Massachusetts, March 18, 2021 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that The New England Journal of Medicine (NEJM) published results from the phase 3 PEGASUS...

Hence then, the article about the nejm publishes phase 3 pegasus study results comparing pegcetacoplan to eculizumab for pnh was published today ( Thursday 18/03/2021 - 03:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( The NEJM publishes phase 3 PEGASUS study results comparing pegcetacoplan to eculizumab for PNH )

Also on site :

• University of Illinois resumes final exams, assignments Sunday after Canvas hack
• I’ve Covered Theme Parks for a Decade and This Is the One Universal Epic Universe Snack You Can’t Miss
• 1971 Bluesy Soul Classic Had One of the Biggest Comebacks in Spotify History, 53 Years After Its Release